The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity

AIDS Research and Therapy

Volumn 11, Issue 1, 2014, Pages

  Widera, Marek ^a   Klein, Antonia N ^b   Cinar, Yeliz ^b   Funke, Susanne A ^b,c   Willbold, Dieter ^a,b   Schaal, Heiner ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

^c Bioanalytik   (Germany)

Author keywords

Alzheimer's disease; Amyloid beta; D enantiomeric peptide; D3; Drugs; HIV 1 infection; Monomers; Oligomers; SEVI

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; DEXTRO AMINO ACID PEPTIDE D3; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTIVITY;

EID: 84892415389     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-11-1     Document Type: Article

References (18)

1. Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H, Schubert D, Riek R. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci USA 2005, 102:17342-17347. 10.1073/pnas.0506723102, 1297669, 16293696.
2. Wojtowicz WM, Farzan M, Joyal JL, Carter K, Babcock GJ, Israel DI, Sodroski J, Mirzabekov T. Stimulation of enveloped virus infection by beta-amyloid fibrils. J Biol Chem 2002, 277:35019-35024. 10.1074/jbc.M203518200, 12119288.
3. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007, 131:1059-1071. 10.1016/j.cell.2007.10.014, 18083097.
4. Roan NR, Munch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J Virol 2009, 83:73-80. 10.1128/JVI.01366-08, 2612336, 18945786.
5. Capule CC, Brown C, Olsen JS, Dewhurst S, Yang J. Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection. J Am Chem Soc 2012, 134:905-908. 10.1021/ja210931b, 3262105, 22239120.
6. Olsen JS, Brown C, Capule CC, Rubinshtein M, Doran TM, Srivastava RK, Feng C, Nilsson BL, Yang J, Dewhurst S. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection. J Biol Chem 2010, 285:35488-35496. 10.1074/jbc.M110.163659, 2975173, 20833717.
7. Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proc Natl Acad Sci USA 2009, 106:9033-9038. 10.1073/pnas.0811827106, 2683882, 19451623.
8. Sievers SA, Karanicolas J, Chang HW, Zhao A, Jiang L, Zirafi O, Stevens JT, Munch J, Baker D, Eisenberg D. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 2011, 475:96-100. 10.1038/nature10154, 21677644.
9. Roan NR, Sowinski S, Munch J, Kirchhoff F, Greene WC. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J Biol Chem 2010, 285:1861-1869. 10.1074/jbc.M109.066167, 2804344, 19897482.
10. Funke AS, van Groen T, Kadish I, Bartnik D, Nagel-Steger L, Brener O, Sehl T, Batra-Safferling R, Moriscot C, Schoehn G, et al. Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's disease transgenic mice. ACS Chem Neurosci 2010, 1:639-648. 10.1021/cn100057j, 3368690, 22778851.
11. Polzer S, Dittmar MT, Schmitz H, Schreiber M. The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology 2002, 304:70-80. 10.1006/viro.2002.1760, 12490404.
12. Chien P, Weissman JS, DePace AH. Emerging principles of conformation-based prion inheritance. Annu Rev Biochem 2004, 73:617-656. 10.1146/annurev.biochem.72.121801.161837, 15189155.
13. Daniel MD, Li Y, Naidu YM, Durda PJ, Schmidt DK, Troup CD, Silva DP, MacKey JJ, Kestler HW, Sehgal PK, et al. Simian immunodeficiency virus from African green monkeys. J Virol 1988, 62:4123-4128. 253843, 3172340.
14. Kikukawa R, Koyanagi Y, Harada S, Kobayashi N, Hatanaka M, Yamamoto N. Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol 1986, 57:1159-1162. 252852, 2419583.
15. Abacioglu YH, Fouts TR, Laman JD, Claassen E, Pincus SH, Moore JP, Roby CA, Kamin-Lewis R, Lewis GK. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses 1994, 10:371-381. 10.1089/aid.1994.10.371, 8068416.
16. Widera M, Erkelenz S, Hillebrand F, Krikoni A, Widera D, Kaisers W, Deenen R, Gombert M, Dellen R, Pfeiffer T, et al. An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA. J Virol 2013, 87:2707-2720. 10.1128/JVI.02755-12, 3571361, 23255806.
17. van Groen T, Wiesehan K, Funke SA, Kadish I, Nagel-Steger L, Willbold D. Reduction of Alzheimer's disease amyloid plaque load in transgenic mice by D3, A D-enantiomeric peptide identified by mirror image phage display. Chem Med Chem 2008, 3:1848-1852. 10.1002/cmdc.200800273, 19016284.
18. Shen R, Richter HE, Smith PD. Early HIV-1 target cells in human vaginal and ectocervical mucosa. Am J Reprod Immunol 2011, 65:261-267. 10.1111/j.1600-0897.2010.00939.x, 3077123, 21118402.